To explore the possible relationship between PSGs and tumor immune landscape, CIBERSORT analysis was performed by assessing differences in estimated tumor immune cell abundance between the PSG+ and PSG− groups in TCGA female LUAD patients (grouped by the signature of PSG3, PSG7, and PSG8 as shown in Fig. 4(a)). This evidence concerns the gene PSG3 and neoplasm.